Literature DB >> 32865112

Suppression of non-homologous end joining does not rescue DNA repair defects in Fanconi anemia patient cells.

Supawat Thongthip1, Brooke A Conti1, Francis P Lach1, Agata Smogorzewska1.   

Abstract

Severe cellular sensitivity and aberrant chromosomal rearrangements in response to DNA interstrand crosslink (ICL) inducing agents are hallmarks of Fanconi anemia (FA) deficient cells. These phenotypes have previously been ascribed to inappropriate activity of non-homologous end joining (NHEJ) rather than a direct consequence of DNA ICL repair defects. Here we used chemical inhibitors, RNAi, and Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)-Cas9 to inactivate various components of NHEJ in cells from FA patients. We show that suppression of DNA-PKcs, DNA Ligase IV, and 53BP1 is not capable of rescuing ICL-induced proliferation defects and only 53BP1 knockout partially suppresses the chromosomal abnormalities of FA patient cells.

Entities:  

Keywords:  53BP1; DNA-PKcs; FANCA; Fanconi anemia; KU70; KU80; LIGIV; mitomycin C; non-homologous end joining

Year:  2020        PMID: 32865112      PMCID: PMC7553586          DOI: 10.1080/15384101.2020.1810394

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  30 in total

1.  Genetic dissection of vertebrate 53BP1: a major role in non-homologous end joining of DNA double strand breaks.

Authors:  Kyoko Nakamura; Wataru Sakai; Takuo Kawamoto; Ronan T Bree; Noel F Lowndes; Shunichi Takeda; Yoshihito Taniguchi
Journal:  DNA Repair (Amst)       Date:  2006-04-27

2.  TGF-β Inhibition Rescues Hematopoietic Stem Cell Defects and Bone Marrow Failure in Fanconi Anemia.

Authors:  Haojian Zhang; David E Kozono; Kevin W O'Connor; Sofia Vidal-Cardenas; Alix Rousseau; Abigail Hamilton; Lisa Moreau; Emily F Gaudiano; Joel Greenberger; Grover Bagby; Jean Soulier; Markus Grompe; Kalindi Parmar; Alan D D'Andrea
Journal:  Cell Stem Cell       Date:  2016-03-24       Impact factor: 24.633

3.  Preventing nonhomologous end joining suppresses DNA repair defects of Fanconi anemia.

Authors:  Adele Adamo; Spencer J Collis; Carrie A Adelman; Nicola Silva; Zuzana Horejsi; Jordan D Ward; Enrique Martinez-Perez; Simon J Boulton; Adriana La Volpe
Journal:  Mol Cell       Date:  2010-07-09       Impact factor: 17.970

4.  Regulation of multiple DNA repair pathways by the Fanconi anemia protein SLX4.

Authors:  Yonghwan Kim; Gabriella S Spitz; Uma Veturi; Francis P Lach; Arleen D Auerbach; Agata Smogorzewska
Journal:  Blood       Date:  2012-10-23       Impact factor: 22.113

5.  Ku70, an essential gene, modulates the frequency of rAAV-mediated gene targeting in human somatic cells.

Authors:  Farjana J Fattah; Natalie F Lichter; Kazi R Fattah; Sehyun Oh; Eric A Hendrickson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-18       Impact factor: 11.205

6.  Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studies.

Authors:  Massimo Bogliolo; Roser Pujol; Miriam Aza-Carmona; Núria Muñoz-Subirana; Benjamin Rodriguez-Santiago; José Antonio Casado; Paula Rio; Christopher Bauser; Judith Reina-Castillón; Marcos Lopez-Sanchez; Lidia Gonzalez-Quereda; Pia Gallano; Albert Catalá; Ana Ruiz-Llobet; Isabel Badell; Cristina Diaz-Heredia; Raquel Hladun; Leonort Senent; Bienvenida Argiles; Juan Miguel Bergua Burgues; Fatima Bañez; Beatriz Arrizabalaga; Ricardo López Almaraz; Monica Lopez; Ángela Figuera; Antonio Molinés; Inmaculada Pérez de Soto; Inés Hernando; Juan Antonio Muñoz; Maria Del Rosario Marin; Judith Balmaña; Neda Stjepanovic; Estela Carrasco; Isabel Cuesta; José Miguel Cosuelo; Alexandra Regueiro; José Moraleda Jimenez; Ana Maria Galera-Miñarro; Laura Rosiñol; Anna Carrió; Cristina Beléndez-Bieler; Antonio Escudero Soto; Elena Cela; Gregorio de la Mata; Rafael Fernández-Delgado; Maria Carmen Garcia-Pardos; Raquel Sáez-Villaverde; Marta Barragaño; Raquel Portugal; Francisco Lendinez; Ines Hernadez; José Manue Vagace; Maria Tapia; José Nieto; Marta Garcia; Macarena Gonzalez; Cristina Vicho; Eva Galvez; Alberto Valiente; Maria Luisa Antelo; Phil Ancliff; Francisco Garcia; Joaquin Dopazo; Julian Sevilla; Tobias Paprotka; Luis Alberto Pérez-Jurado; Juan Bueren; Jordi Surralles
Journal:  J Med Genet       Date:  2019-10-05       Impact factor: 6.318

7.  A 20-year perspective on the International Fanconi Anemia Registry (IFAR).

Authors:  David I Kutler; Bhuvanesh Singh; Jaya Satagopan; Sat Dev Batish; Marianne Berwick; Philip F Giampietro; Helmut Hanenberg; Arleen D Auerbach
Journal:  Blood       Date:  2002-09-26       Impact factor: 22.113

8.  Human LIGIV is synthetically lethal with the loss of Rad54B-dependent recombination and is required for certain chromosome fusion events induced by telomere dysfunction.

Authors:  Sehyun Oh; Yongbao Wang; Jacob Zimbric; Eric A Hendrickson
Journal:  Nucleic Acids Res       Date:  2012-12-28       Impact factor: 16.971

9.  53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers.

Authors:  Peter Bouwman; Amal Aly; Jose M Escandell; Mark Pieterse; Jirina Bartkova; Hanneke van der Gulden; Sanne Hiddingh; Maria Thanasoula; Atul Kulkarni; Qifeng Yang; Bruce G Haffty; Johanna Tommiska; Carl Blomqvist; Ronny Drapkin; David J Adams; Heli Nevanlinna; Jiri Bartek; Madalena Tarsounas; Shridar Ganesan; Jos Jonkers
Journal:  Nat Struct Mol Biol       Date:  2010-05-09       Impact factor: 15.369

10.  53BP1 is required for class switch recombination.

Authors:  Irene M Ward; Bernardo Reina-San-Martin; Alexandru Olaru; Kay Minn; Koji Tamada; Julie S Lau; Marilia Cascalho; Lieping Chen; Andre Nussenzweig; Ferenc Livak; Michel C Nussenzweig; Junjie Chen
Journal:  J Cell Biol       Date:  2004-05-24       Impact factor: 10.539

View more
  1 in total

1.  Testicular Germ Cell Tumors Acquire Cisplatin Resistance by Rebalancing the Usage of DNA Repair Pathways.

Authors:  Cinzia Caggiano; Francesca Cavallo; Teresa Giannattasio; Gioia Cappelletti; Pellegrino Rossi; Paola Grimaldi; Darren R Feldman; Maria Jasin; Marco Barchi
Journal:  Cancers (Basel)       Date:  2021-02-13       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.